09/15/2026
🩺 Diagnostic uncertainty in suspected infection drives unnecessary admissions, longer stays, and inappropriate antimicrobial use.
This session explores the real-world utility of LIAISON® MeMed BV®, a host-response assay that differentiates bacterial and viral infections. Learn how it's influencing clinical decision-making and operational metrics in a U.S. healthcare system, plus a practical framework for justifying adoption when value extends beyond the lab.
September 21, 2026 | 9:00 AM PT / 12:00 PM EDT / 6:00 PM CET
Sign up now:
https://buff.ly/qXdwmhT
Diagnostic uncertainty in suspected infection drives unnecessary admissions, prolonged length of stay, and inappropriate antimicrobial use—while laboratories face increasing pressure t